Keyphrases
Natural Killer Cells
100%
Natural Killer Cell Subsets
100%
Viral Infection
100%
Natural Killer Cell Deficiency
100%
Vaginal Dysbiosis
100%
Mismanagement
100%
Vaginal Microbiome
100%
HIV Epidemic
100%
Inappropriate Treatment
100%
HIV Susceptibility
40%
HIV Acquisition Risk
40%
Dysregulation
30%
Hyporesponsive
20%
Cell Population
20%
Therapeutic Approaches
20%
Inflammation Status
20%
HIV Pandemic
20%
Lactobacillus Crispatus
20%
Immune Parameters
20%
Recent HIV Infection
20%
Decreased Risk
20%
Bacterial Vaginosis
20%
Engineered Bacteria
20%
Microbiome
20%
HIV Persistence
20%
HIV Prevention
20%
Lactobacillus
20%
Vulnerable Populations
20%
Complementary Strategy
20%
Drug Levels
20%
Most Vulnerable
20%
Probiotic Bacteria
20%
High Diversity
20%
HIV Incidence
20%
Bacteriophage
20%
Low Diversity
20%
Antibiotics
20%
Hyperinflammation
10%
Natural Killer Cell Therapy
10%
Viral Persistence
10%
Engager
10%
Viral Challenge
10%
Viral Disease
10%
Population Shift
10%
Host Cell Death
10%
Viral Pathogenesis
10%
Emerging Therapeutics
10%
Immune Responders
10%
Immune Checkpoint Inhibitors
10%
Immunology and Microbiology
Natural Killer Cell
100%
Viral Disease
100%
Human Immunodeficiency Virus
100%
Microbiome
66%
Cell Population
29%
Immunity
18%
Probiotic
11%
Human Immunodeficiency Virus Infection
11%
Lactobacillus
11%
Vulnerable Population
11%
Drug Concentration
11%
Lactobacillus crispatus
11%
Immunocompetent Cell
11%
Bacteriophage
11%
Viral Pathogenesis
9%
Cell Death
9%
Chimeric Antigen Receptor Natural Killer Cell
9%
Prevalence
9%
Host Cell
9%
Medicine and Dentistry
Dysbiosis
100%
Human Immunodeficiency Virus
100%
Microbiome
66%
Lactobacillus
11%
Cell Population
11%
Antibiotics
11%
Lactobacillus crispatus
11%
Probiotic Agent
11%
Bacterial Vaginosis
11%
Vulnerable Population
11%
Immunocompetent Cell
11%
Human Immunodeficiency Virus Infection
11%
Bacteriophage
11%
